BAY-3153 |
BAY-3153 : Antagonist of CCR1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CCR1 |
|
Antagonist
100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selectivity within target family: Inactive on CCR3 (human); IC50 > 30 µM for human CCR2, CCR4, CCR5, ...
Potency Cellular
In Vitro
CCR1
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
Other Reference: peer reviewed at SGC
In Vivo Validations
Negative Control Compounds
BAY-173
Notes: BAY-173 with 400-fold less in vitro potency (IC50 = 1200 nM (human), 8500 nM (mice); biochemical CCR1 assay); Shows weak activity in the GPCR scan: The closest off-target is SLC6A4 (SERT) (Ki = 1460.83 nM)
Chemical Information
| Molecular Formula | C25H29Cl2N3O4 |
| SMILEs | CCOc1cc(N2C3COCC2CN(C(=O)[C@H]2C[C@H](O)CN2c2ccc(Cl)cc2)C3)ccc1Cl |
| InChI | InChI=1S/C25H29Cl2N3O4/c1-2-34-24-9-18(7-8-22(24)27)30-19-11-28(12-20(30)15-33-14-19)25(32)23-10-21(31)13-29(23)17-5-3-16(26)4-6-17/h3-9,19-21,23,31H,2,10-15H2,1H3/t19?,20?,21-,23+/m0/s1 |
| Molecular weight | 505.15 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 63 |